Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
Abstract The use of sacubitril/valsartan significantly reduces death or hospitalization in patients with ejection fraction < 40%. There is no study evaluating this drug effects in non‐compaction cardiomyopathy (NCCM) individuals. The aim of this article is to report a case of a patient with NCCM ini...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020-06-01
|
| Serija: | ESC Heart Failure |
| Teme: | |
| Online pristup: | https://doi.org/10.1002/ehf2.12713 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|